气球肺血管整形术的最佳短期结果:每年至少三次会议的最低频率
Xin Li1, Tao Yang1, Yi Zhang1,2
1Center for Respiratory and Pulmonary Vascular Diseases, National Center for Cardiovascular Diseases, National Clinical Research Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Fuwai Hospital, Beijing, China.
Therapeutic advances in respiratory disease
|February 27, 2024
概括
对于慢性血栓栓塞性肺高血压,建议在六个月内至少进行两次气球肺血管整形 (BPA),以获得最佳的短期结果. 为了持续改善,可能需要更多的会议.
科学领域:
- 心脏病学 心脏病学
- 肺高血压是什么意思 肺高血压
- 干预心脏病学 干预心脏病学
背景情况:
- 气球肺血管整形 (BPA) 是慢性血栓栓塞性肺高血压 (CTEPH) 的标准治疗方法.
- 顺序治疗是典型的,但实现目标的最佳频率尚不清楚.
研究的目的:
- 确定在CTEPH患者中实现治疗目标所需的BPA疗程的最低频率.
- 为了确定治疗强度的值 (疗程,治疗容器,治疗比率) 以获得短期结果.
主要方法:
- 对186名接受BPA治疗的CTEPH患者进行了回顾性队列研究.
- 患者按BPA治疗次数,累计治疗血管和治疗与损伤比率 (T/P) 分层.
- 主要结局是临床恶化;分析了无生存率.
主要成果:
- 16.7%的患者经历了临床恶化.
- 6个月内≥2次BPA疗程的无恶化存活率明显高于1次疗程.
- 在6个月的最佳短期结果需要≥2次治疗,≥9个治疗容器,或T/P≥0.790.
结论:
- 通过BPA在CTEPH中实现最佳的短期结果需要特定的治疗强度.
- 在6个月后,建议进行≥2次会议,≥9个经过处理的血管,或T/P≥0.790.
- 在12个月后,≥3个疗程,≥17个经过治疗的血管,或T/P≥1.264都适用于持续的益处.
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
181
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
181
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
214
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
214
01:27Pneumothorax-II
146
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
146